Autism Spectrum Disorder
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that begins in early childhood, affecting social interaction, communication, and learning, and is characterized by restricted, repetitive behaviors, and varying degrees of sensory sensitivity and social communication challenges. As a spectrum disorder, autism manifests differently in each individual, leading to a wide variation in support needs and abilities.
Health Outcomes
- Altered Neurobiological Markers
- Altered Pyridoxine Concentration
- Changed Functional Connectivity
- Genome Sequencing / Genome Characterization
- Improved ASD Symptoms
- Improved Adaptive Functioning
- Improved Agility and Coordination Performance
- Improved Analytical Accuracy
- Improved Attention Span
- Improved Autism Behavioral Scores
- Improved Autism Spectrum Disorder Symptoms
- Improved Autistic Disorder
- Improved Behavior
- Improved Behavioral Abnormalities
- Improved Behavioral Symptoms in Younger Children
- Improved Child Neurodevelopment
- Improved Child Neurodevelopment (Adaptive Domain)
- Improved Child Neurodevelopment (Motor Domain)
- Improved Child Neurophysiological Outcome
- Improved Cognitive Behavior
- Improved Communication
- Improved Communication Skills
- Improved Delta Power in EEG
- Improved Developmental Milestone
- Improved Emotional Dysregulation
- Improved Emotional and Behavioral Changes
- Improved Executive Function
- Improved Expressive Language
- Improved Flexibility or Set Shift
- Improved Full Scale Intelligence Quotient
- Improved Global Assessment
- Improved Glutathione Level
- Improved Gut-Brain Axis Homeostasis
- Improved Gut-Brain Axis Related Neurobehavioral Measures
- Improved Gut-Brain Axis-Related Neuropsychiatric Health
- Improved Inhibitory Control
- Improved Inhibitory Executive Process
- Improved Language Development
- Improved Language Outcome
- Improved Language Score
- Improved Learning
- Improved Mental Developmental Quotient
- Improved Motor Skill Development
- Improved Neurobehavioral Function
- Improved Neurodevelopmental Performance
- Improved Neurological Health
- Improved Neurotransmitter Metabolism
- Improved Opposition and Defiance Behaviors
- Improved Parent/Caregiver Quality of Life
- Improved Performance Developmental Score
- Improved Performance Mastery
- Improved Personal-Social Developmental Score
- Improved Problem-Solving Skills
- Improved School Functioning
- Improved Set Shifting Ability
- Improved Set-Shifting
- Improved Set-Shifting Reaction Time
- Improved Social Behavior
- Improved Social Emotional Cognition
- Improved Social Functioning
- Improved Social Functioning Quality of Life
- Improved Social Satisfaction
- Improved Socialization
- Improved Spatial Working Memory
- Improved Specific Elements of ASD Behaviors
- Improved Synaptic Plasticity
- Improved Target-Distractor Discriminability
- Improved Temperament
- Increased Attachment Gain
- Increased Bacteroides Count
- Increased Bifidobacteria Growth
- Increased Bifidobacterium Proportion
- Increased Bifidobacterium longum Relative Abundance
- Increased Cortical Thickness
- Increased Gray Matter Volume
- Increased Head Circumference
- Increased Oxytocin Synthesis in the Hypothalamus
- Increased Plasma Kynurenic Acid Levels
- Increased Plasma Serotonin Levels
- Increased Postsynaptic Density Protein 95 Levels
- Increased Propionic Acid Levels
- Increased Propionic Acid Production
- Increased Salivary Oxytocin Level
- Increased Social Avoidance
- Increased Sulfate Metabolite Level
- Maintained Normal Behavior
- Modified Resting-State Brain Connectivity
- Modulated Microbiota-Gut-Brain Axis
- No Change in Plasma GABA Levels
- No Significant Difference Compared to Placebo
- Normalized Neurotransmitter Levels
- Reduced Aberrant Behavior Checklist Score
- Reduced Adverse Neurodevelopmental Outcome
- Reduced Autism Rating Scale Behavior Subscale Score
- Reduced Autism Rating Scale Score
- Reduced Autism Severity
- Reduced Autism Symptom Severity
- Reduced Autism Treatment Evaluation Checklist Score
- Reduced Autistic-Like Behavioral Symptoms
- Reduced Bacteroides/Prevotella Count
- Reduced Behavioral Difficulty
- Reduced Behavioral Problem
- Reduced Behavioral Problems
- Reduced Behavioral Symptoms
- Reduced Brain Inflammation
- Reduced Cortical Excitation
- Reduced D-Lactate Production
- Reduced Error Rate on Neutral Stroop Task
- Reduced Food Safety Risk
- Reduced Gilliam Autism Rating Scale Communication Subscale Score
- Reduced Gilliam Autism Rating Scale Socialization Subscale Score
- Reduced Individual Variability
- Reduced Indoleamine 2,3-Dioxygenase Activity
- Reduced Irritability
- Reduced Kynurenine-Tryptophan Ratio
- Reduced Learning Problems
- Reduced Neural Aggregation
- Reduced Neuroinflammatory Markers
- Reduced Oppositional/Defiant Behaviors
- Reduced P3b Amplitude
- Reduced Plasma LPS Levels
- Reduced Prefrontal Cortex Activation
- Reduced Prefrontal Cortex Oxygenated Hemoglobin
- Reduced Rearing Behavior
- Reduced Repetitive Behaviors
- Reduced Response Time on Flanker Task
- Reduced Self-Injurious Behavior
- Reduced Serum Malondialdehyde Levels
- Reduced Set-Shifting Reversal Error
- Reduced Stereotypic Behavior
- Reduced Sulphite-Reducing Clostridia
- Regulation of Neuroactive Ligand Receptor Interaction Pathway